Pharma Archives - Page 4 of 88 - Boston Life Sciences Times

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

March 3, 2026

THIS WEEK'S STORIES

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

March 3, 2026

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

March 3, 2026

Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team

March 3, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Study Suggests Daily Multivitamin May Slow Biological Aging

Parabilis Medicines Reports Early Clinical Data Showing Zolucatetide Reduces Polyp Burden in Familial Adenomatous Polyposis

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

KalVista Highlights Patient Satisfaction, Early Treatment Benefits for EKTERLY at Major Allergy Meetings

Merck Unveils Late-Breaking Phase 3 Data on Doravirine/Islatravir HIV Regimen at CROI 2026

Most Read

Newton Women’s Health Company Reports Study Showing Leva Device Improves Fecal Incontinence Symptoms

Study Suggests Daily Multivitamin May Slow Biological Aging

FDA Grants Priority Review to ENHERTU for High-Risk HER2-Positive Early Breast Cancer

UK Biotech Firm Abselion Opens U.S. Subsidiary in Cambridge Innovation Hub

EDITOR PICKS

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

THIS WEEK'S STORIES

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team

POPULAR CATEGORY

ABOUT US

FOLLOW US